[1]
|
Sia, D., Jiao, Y., Martinez-Quetglas, I., et al. (2017) Identification of an Immune-Specific Class of Hepatocellular Carcinoma, Based on Molecular Features. Gastroenterology, 153, 812-826. https://doi.org/10.1053/j.gastro.2017.06.007
|
[2]
|
Dzhandzhugazyan, K.N., Guldberg, P. and Kirkin, A.F. (2018) Adoptive T Cell Cancer Therapy. Nature Materials, 17, 475-477. https://doi.org/10.1038/s41563-018-0094-5
|
[3]
|
Gammaitoni, L., Giraudo, L., Macagno, M., et al. (2017) Cytokine-Induced Killer Cells Kill Chemo-Surviving Melanoma Cancer Stem Cells. Clinical Cancer Research, 23, 2277-2288. https://doi.org/10.1158/1078-0432.CCR-16-1524
|
[4]
|
Cornel, A.M., van Til, N.P., Boelens, J.J., et al. (2018) Strategies to Genetically Modulate Dendritic Cells to Potentiate Anti-Tumor Responses in Hematologic Malignancies. Frontiers in Immunology, 9, 982.
https://doi.org/10.3389/fimmu.2018.00982
|
[5]
|
Shin, C., Han, J.A., Koh, H., et al. (2015) CD8alpha(-) Dendritic Cells Induce Antigen-Specific T Follicular Helper Cells Generating Efficient Humoral Immune Responses. Cell Reports, 11, 1929-1940.
https://doi.org/10.1016/j.celrep.2015.05.042
|
[6]
|
Dou, L., Ono, Y., Chen, Y.F., et al. (2018) Hepatic Dendritic Cells, the Tolerogenic Liver Environment, and Liver Disease. Seminars in Liver Disease, 38, 170-180. https://doi.org/10.1055/s-0038-1646949
|
[7]
|
El Ansary, M., Mogawer, S., Elhamid, S.A., et al. (2013) Immunotherapy by Autologous Dendritic Cell Vaccine in Patients with Advanced HCC. Journal of Cancer Research and Clinical Oncology, 139, 39-48.
https://doi.org/10.1007/s00432-012-1298-8
|
[8]
|
Brombacher, E.C. and Everts, B. (2020) Shaping of Dendritic Cell Function by the Metabolic Micro-Environment. Frontiers in Endocrinology (Lausanne), 11, 555. https://doi.org/10.3389/fendo.2020.00555
|
[9]
|
Dobrovolskienė, N., Pašukonienė, V., Darinskas, A., Kraśko, J.A., Žilionytė, K., Mlynska, A., et al. (2018) Tumor Lysate-Loaded Bacterial Ghosts as a Tool for Optimized Production of Therapeutic Dendritic Cell-Based Cancer Vaccines. Vaccine, 36, 4171-4180. https://doi.org/10.1016/j.vaccine.2018.06.016
|
[10]
|
Sabado, R.L., Balan, S. and Bhardwaj, N. (2017) Dendritic Cell-Based Immunotherapy. Cell Research, 27, 74-95.
https://doi.org/10.1038/cr.2016.157
|
[11]
|
Ahmed, M.S. and Bae, Y.S. (2014) Dendritic Cell-Based Therapeutic Cancer Vaccines: Past, Present and Future. Clinical and Experimental Vaccine Research, 3, 113-116. https://doi.org/10.7774/cevr.2014.3.2.113
|
[12]
|
Chen, J.L., Lao, X.M., Lin, X.J., et al. (2016) Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma after Curative Resection, Medicine (Baltimore), 95, e2665. https://doi.org/10.1097/MD.0000000000002665
|
[13]
|
Durrieu, L., Lemieux, W., Dieng, M.M., et al. (2014) Implication of Different Effector Mechanisms by Cord Blood-Derived and Peripheral Blood-Derived Cytokine-Induced Killer Cells to Kill Precursor B Acute Lymphoblastic Leukemia Cell Lines. Cytotherapy, 16, 845-856. https://doi.org/10.1016/j.jcyt.2013.12.010
|
[14]
|
Chen, D., Sha, H., Hu, T., et al. (2018) Cytokine-Induced Killer Cells as a Feasible Adoptive Immunotherapy for the Treatment of Lung Cancer. Cell Death & Disease, 9, Article No. 366. https://doi.org/10.1038/s41419-018-0404-5
|
[15]
|
Yu, B., Wang, J., He, C., et al. (2017) Cytokine-Induced Killer Cell Therapy for Modulating Regulatory T Cells in Patients with Non-Small Cell Lung Cancer. Experimental and Therapeutic Medicine, 14, 831-840.
https://doi.org/10.3892/etm.2017.4562
|
[16]
|
Pan, K., Li, Y.Q., Wang, W., Xu, L., Zhang, Y.J., Zheng, H.X., et al. (2013) The Efficacy of Cytokine-Induced Killer Cell Infusion as an Adjuvant Therapy for Postoperative Hepatocellular Carcinoma Patients. Annals of Surgical Oncology, 20, 4305-4311. https://doi.org/10.1245/s10434-013-3144-x
|
[17]
|
Schmeel, L.C., Schmeel, F.C., Coch, C. and Schmidt-Wolf, I.G. (2015) Cytokine-Induced Killer (CIK) Cells in Cancer Immunotherapy: Report of the International Registry on CIK Cells (IRCC). Journal of Cancer Research and Clinical Oncology, 141, 839-849. https://doi.org/10.1007/s00432-014-1864-3
|
[18]
|
Yu, R., Yang, B., Chi, X., et al. (2017) Efficacy of Cytokine-Induced Killer Cell Infusion as an Adjuvant Immunotherapy for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Drug Design, Development and Therapy, 11, 851-864. https://doi.org/10.2147/DDDT.S124399
|
[19]
|
Lee, J.H., Lee, J.H., Lim, Y.S., Yeon, J.E., Song, T.J., Yu, S.J., Gwak, G.Y., Kim, K.M., Kim, Y.J., Lee, J.W. and Yoon, J.H. (2015) Adjuvant Immunotherapy with Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma. Gastroenterology, 148, 1383-1391.e6. https://doi.org/10.1053/j.gastro.2015.02.055
|
[20]
|
Bonanno, G., Iudicone, P., Mariotti, A., et al. (2010) Thymoglobulin, Interferon-Gamma and Interleukin-2 Efficiently Expand Cytokine-Induced Killer (CIK) Cells in Clinical-Grade Cultures. Journal of Translational Medicine, 8, Article No. 129. https://doi.org/10.1186/1479-5876-8-129
|
[21]
|
Chen. C.L., Pan, Q.Z., Weng, D.S., et al. (2018) Safety and Activity of PD-1 Blockade-Activated DC-CIK Cells in Patients with Advanced Solid Tumors. Oncoimmunology, 7, e1417721. https://doi.org/10.1080/2162402X.2017.1417721
|
[22]
|
Zhang, J., Li, H., Gao, D., et al. (2018) A Prognosis and Impact Factor Analysis of DC-CIK Celltherapy for Patients with Hepatocellular Carcinoma Undergoing Postoperative TACE. Cancer Biology & Therapy, 19, 475-483.
https://doi.org/10.1080/15384047.2018.1433501
|
[23]
|
Ma, Y.J., He, M., Han, J.A., et al. (2013) A Clinical Study of HBsAg-Activated Dendritic Cells and Cytokine-Induced Killer Cells during the Treatment for Chronic Hepatitis B. Scandinavian Journal of Immunology, 78, 387-393.
https://doi.org/10.1111/sji.12097
|
[24]
|
Brudno, J.N. and Kochenderfer, J.N. (2018) Chimeric Antigen Receptor T-Cell Therapies for Lymphoma. Nature Reviews Clinical Oncology, 15, 31-46. https://doi.org/10.1038/nrclinonc.2017.128
|
[25]
|
June, C.H., O’Connor, R.S., Kawalekar, O.U., Ghassemi, S. and Milone, M.C. (2018) CAR T Cell Immunotherapy for Human Cancer. Science, 359, 1361-1365. https://doi.org/10.1126/science.aar6711
|
[26]
|
Lim, W.A. and June, C.H. (2017) The Principles of Engineering Immune Cells to Treat Cancer. Cell, 168, 724-740.
https://doi.org/10.1016/j.cell.2017.01.016
|